DR. CLAUDIA ULBRICH

 

Dr. Claudia Ulbrich, founder and managing partner of ulbrich&partner, is a MD and health econ- omist by training with >25 years of expertise in the life-science industry and a broad range of senior-level experience in consulting & management as well as serial entrepreneur. Founder, Co-Founder & CEO of several biotechs.

A strategically thinking manager and integrative leader, proven track record in strategy, finance, R&D, market access, M&A and transaction management. Claudia supports biotech clients in Europe and has worked with the top 10 pharma companies. Transaction record up to >2bn USD. Claudia holds board positions in relevant public & trade organizations.

January 2008 – present Advisory mandates at ulbrich&partner for various pharmaceutical companies including a Dutch biopharmaceutical company, a German mid-sized pharma supplier, a US orphan drug company et al., a range of international high-tech and biotech companies and organizations as well as international investors.

January 2008 – December 2011 Advisory mandates at PwC as a Senior Advisor pharma/life science including guidance on new biotech business, execution of industry surveys and comprehensive contribution to projects for contracting authorities, e.g. BMBF/BMG.

October 1998 – September 2006 Founder and CEO of LipoNova AG, a stock-listed biotech company in oncology and cancer vaccines.

March 1995 – September 1998 Medical Director at macropharm, a mid-sized pharmaceutical company focussed on oncology.

February 1993 – February 1995 Medical doctor at Medical School Lübeck and Warnsdorf clinics.

Memberships and Affiliations

  • Member of the Advisory Board of the Federal Ministry of Economics and Technology from 2003 until 2010
  • Member of the Advisory Board of the Institute of Economics of Northern Germany since 2005, full member since 2000
  • Member of the Advisory Board of BioregionN from 2010 until 2014
  • Recipient of the Women´s Advancement in Business Award of the capital of the state of Lower Saxony in 2004
  • Member of the BIO Deutschland since 2005 (founding member)
  • Coach and partner of Science4Life since 2009
  • Co-founder of the foundation PA.T.H – Patients Tumorbank of Hope since 2001
  • Member of the Professional Company of Physicians for Pharmaceutical Medicine (DGPharMed) since 1996
  • Member of the German Society for Law and Politics in the Healthcare Sector since 2004
  • Member of Rotary since 2005
  • Member of Friends’ Association (“Förderverein”) of ISHR (International School Hanover Region) since 2001

Andreas Kranzusch

 

Andreas Kanzusch is a banker by training with a degree in computer science. He works as a senior consultant and senior analyst of ulbrich&partner in finance and administration with >16 years of experience in leading positions in start-up life-science companies.

Long-term expertise in transferring business and scientific ideas to financial planning and corporate structures. Former CFO of EMCID, greenovation, t-cell and CFOxt. Reviewer at Science4Life, coach at BWCON.

2009 – present Freelance consultant and interim manager with focus on finance and administration of small life-science companies:

  • CFO-position (interim management) for a spin-off company of Charité (Berlin) developing cell therapies
  • Setting up business model and financial planning for a university spin-off in the area of gene therapy
  • Developing lean start-up businessmodel, setting up financial planning for a university spin-off developing and producing innovative biomaterials for research and regenerative medicine
  • Interim management, finance and administration, setting up quality management incl. accrediting to German authorities for an world-wide active German human genetics diagnostic company

2012- present Co-founder and CEO of CFOxt – a company offering managerial accounting and reporting services to start-ups and entrepreneurs

2009-2013 Co-founder and CFO Emcid Biotech GmbH, a Freiburg based biotech company focused on secondary metabolites and biomaterials from plant cell culture, successfully acquired in 2013 by US pharma company.

2001-2009 CFO and CEO (2005) at greenovation Biotech GmbH, a leading company in the area of recombinant protein production in plant cells

Membership and labels Accredited to BWCON
Reviewer Science4life business plan competition

Dr. Christian Hanke

 

Dr. Christian Hanke (Partner) has more than 20 years of management expertise in medtech, diagnostic, and pharmaceutical companies. He holds a PhD in molecular biology and an additional MSc in Drug Regulatory Affairs.

By heading cross-functional R&D and commercialization teams he successfully conducted projects from idea to commercial launch including change management projects. Christian is a performance-based leader with broad expertise in Business Development, Tech-Scouting and Marketing & Sales and was successful in commercializing both services & products internationally.

Christian is a technological enthusiast and inspired by the vision of value added drug - diagnostics combinations to the benefit of the patient.

    2013 – Present Business Development Consultant with a focus on diagnostics & pharmaceuticals

    Driving medical device development projects with internal resources and external partners Acquisition of beta-testers and opinion leaders Continuous control of budget and resources, setup of strategic business & launch plans Input for project strategies & market analysis Assessment and valuation of technical solutions regarding regulatory requirements and commercial viability Regulatory intelligence

    2010 - 2012 Manager & Senior Manager Regulatory Affairs / Pharmaceuticals

    Coauthored Investigator Brochures, Drug Safety Reports, Orphan designations & Scientific Advice Wrote and implemented SOPs for Regulatory Affairs Responsible for the implementation of an electronic data management systems (eDMS) and (eCTD)

    2009 - 2010 Consultant Project Management Consultant / Diagnostics

    Coordinated clinical studies Contributed to class 2a Medical Device registration in the field a dentistry

    2008 -2009 VP Business Development OLED-Biosensors / Diagnostics

    Recruited early adopter industry partners to beta test new technologies Defined & projected novel biosensor formats for Point of Care applications Prepared market analysis and reports to evaluate customer needs Developed in- and out-licensing strategies and term sheets

    2006 – 2007 Business Development Consultant & Managing Partner / Life Sciences

    Participated in a series A fundraising Supported and managed beta site evaluations and customer acquisitions Analyzed market with regards to pricing & reimbursement opportunities Created launch plan for Germany

    2001-2005 Director Bioscience / Life Sciences / Diagnostics

    R&D and sales of advanced biochip platforms Directed an interdisciplinary team of 11 engineers, (bio-)physicists, electronics engineers, chemists, biologists, and one sales manager

    1997 – 2000 General Manager / Diagnostics

    Shared responsibility for setting up a IVD company and all departments Leading the heads of R&D, QM, PM, and 4 sales reps Key account management for selected customers Launched more than 10 proprietary in-vitro diagnostics tests

    1994 - 1997 Senior Product Manager / Diagnostics

    1991 – 1994 Clinical Research Associate, Medical Manager / Pharmaceuticals

    Membership & Awards

    • Förderpreis / Scholarship Award 2013 (endowed with 5.000€) for an excellent publication in the field of drug regulatory affairs, German Society of Drug Regulatory Affairs, Bonn Study Award 2012 (endowed with 1.000€) for an excellent master thesis in the field of drug regulatory affairs, German Society of DRA, Bonn
    • Member of the German Society of Drug Regulatory Affairs, Bonn
    • Member of m4 Personalized Medicine e.V.

Dr. Steffen Rump

 

Dr. Steffen Rump is a biologist by training and an expert in translational drug development with more than 6 years of experience in product development in the biotechnological and pharmaceutical industry. This includes planning and coordination of non-clinical and quality development, CMC, QM, clinical development and regulatory interactions in nearly all phases along the pharmaceutical valuation chain. After being postdoc at Harvard Medical School he was Project Manager and Consultant at Vakzine Projekt Management GmbH.

    2017 - Present Freelance Consultant and Project Manager for product development in the biotechnological and pharmaceutical industry.

    2012 – 2017 Project Manager and Consultant at Vakzine Projekt Management GmbH, supporting clients in nearly all phases of the pharmaceutical development chain. Including but not limited to identification and evaluation of candidates, planning and coordination of product development, and support in partnering and out-licensing activities.

    2016 – 2017 Quality Assurance Manager at Vakzine Projekt Management GmbH responsible for quality assurance management and maintenance. Setting up and maintaining QA structures at the interface of GxP and ISO 9001 compliant quality management systems.

    2010 – 2011 Postdoctoral research fellow at Harvard Medical School working on micronutrient related crosstalks that take part in the redox metabolism and regulation of human cells.

    Membership & Awards

    • 2010 – 2011 Postdoctoral research fellowship from German academic exchange service (DAAD)
    • November 2006 Georg-Christoph-Lichtenberg Scholarship - to support the careers of excellent young scientists
    • December 2005 Award “Braunschweiger Bürgerpreis“ for outstanding student achievements and special commitment at Braunschweig University of Technology
    • 2005 - 2006 Scholarship of the German National Academic Foundation (Studienstiftung des deutschen Volkes). Germany’s largest and oldest sponsorship organisation for the academically gifted

Vanessa Krukenberg

 

Vanessa Krukenberg, is a successful entrepreneur, experienced management consultant and project manager with a degree in business economics. She brings over 15 years of management and consultant experience into her work at ulbrich&partner.

Vanessa has a longtime experience in the management consultancy business as project manager for national and international customers implementing numerous change processes with specific focus on providing training and coaching to senior executive management.

As project manager in Royal Dutch Shell, she successfully led multi-national projects, managed international teams and external stakeholders. Furthermore, she developed and implemented innovative strategies to expand Shells´ gas business across Europe.

Vanessa is an entrepreneur having founded various companies in business consultancy, cultural management and event moderation.

She is fluent in English, Spanish, Dutch and French and a certified coach and business trainer.

    Joined ulbrich&partner 2019 as Senior Consultant

    2015-2018

    • Founder and Managing Director of you&culture, a company offering business consultancy in the field of strategy and change management,
    • Co-founder of 42.0 Beratung GmbH, a company providing political consultancy and networking services,
    • Presenter of events and centre stage discussions

    2013-2015 Associate and project manager at Siers & Collegen, a company focusing on management consultancy; responsible for project planning and implementation, leadership development, management reporting, workshop conception and execution

    2008-2012

    • Founder and Managing Director of you&culture, focusing on the development of company cultures as well as top-/senior management leadership skills,
    • Certified business coach and trainer

    2001-2008 International business career within RoyalDutch Shell and within a joint venture of ExxonMobil and Shell; various leading roles held with assignments in Germany, The Netherlands and United Kingdom;

    • Strategy Advisor for Shell Energy Europe in The Hague
    • Project Manager for the implementation of a key Pan-European IT solution for Shell Energy Europe in London
    • Key account management for industrial customers and local distribution companies in the German gas market
    • Gas Purchase Advisor for long term gas contracts from Denmark, Norway and Russia

    Memberships and qualifications

    • Member oft the Board of Freiwilligenzentrum Hannover e.V.
    • Certified Business Coach
    • Certified Business Trainer
    • Qualified presenter
    • Business fluent languages: English, Spanish, Dutch and French

Schliessen

Impressum

ulbrich&partner management consulting
Claudia Ulbrich MD
Güntherstraße 7A | 30519 Hannover | Germany | Mobile +49 (0) 172 / 455 76 32
Phone +49 (0) 511 / 37 48 40 51
info@ulbrichpartner.com
Geschäftsführung: Dr. Claudia Ulbrich

1. Content
The author reserves the right not to be responsible for the topicality, correctness, completeness or quality of the information provided. Liability claims regarding damage caused by the use of any information provided, including any kind of information which is incomplete or incorrect, will therefore be rejected. All offers are not-binding and without obligation. Parts of the pages or the complete publication including all offers and information might be extended, changed or partly or completely deleted by the author without separate announcement.

2. Referrals and links
The author is not responsible for any contents linked or referred to from his pages - unless he has full knowledge of illegal contents and would be able to prevent the visitors of his site from viewing those pages. If any damage occurs by the use of information presented there, only the author of the respective pages might be liable, not the one who has linked to these pages. Furthermore the author is not liable for any postings or messages published by users of discussion boards, guestbooks or mailing lists provided on his page.

3. Copyright
The author intended not to use any copyrighted material for the publication or, if not possible, to indicate the copyright of the respective object. The copyright for any material created by the author is reserved. Any duplication or use of objects such as images, diagrams, sounds or texts in other electronic or printed publications is not permitted without the author's agreement.

4. Privacy policy
If the opportunity for the input of personal or business data (email addresses, name, addresses) is given, the input of these data takes place voluntarily. The use and payment of all offered services are permitted - if and so far technically possible and reasonable - without specification of any personal data or under specification of anonymized data or an alias. The use of published postal addresses, telephone or fax numbers and email addresses for marketing purposes is prohibited, offenders sending unwanted spam messages will be punished.

5. Legal validity of this disclaimer
This disclaimer is to be regarded as part of the internet publication which you were referred from. If sections or individual terms of this statement are not legal or correct, the content or validity of the other parts remain uninfluenced by this fact.

Schliessen